Cross-cultural adaptation and linguistic validation of age-group-specific haemophilia patient-reported outcome (PRO) instruments for patients and parents

Haemophilia

Volumn 19, Issue 2, 2013, Pages

  von Mackensen, S ^a   Campos, I G ^b   Acquadro, C ^c   Strandberg Larsen, M ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MAPI Institute   (France)

^c MAPI Research Trust   (France)

^d NOVO NORDISK A S   (Denmark)

Author keywords

Age specific instruments; Haemophilia; Health related quality of life; Linguistic validation; Patient reported outcomes; Treatment satisfaction

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CULTURAL ANTHROPOLOGY; HEMOPHILIA; HUMAN; LINGUISTICS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOCIAL ADAPTATION; VALIDATION PROCESS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-CULTURAL COMPARISON; FEMALE; HEMOPHILIA A; HUMANS; LINGUISTICS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PARENTS; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84874115622     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12054     Document Type: Article

References (49)

1. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003; 361: 1801-9.
2. White GC2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560.
3. Orphanet. 2012. The Portal for Rare Diseases and Orphan Drugs. Available at http://www.orpha.net/consor/cgi-bin/index.php?lng=EN. Accessed February 01, 2012.
4. Manco-Johnson MJ, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb Hemost 2003; 29: 585-94.
5. Manco-Johnson MJ. Update on treatment regimens: prophylaxis versus on-demand therapy. Semin Hematol 2003; 40: 3-9.
6. Montgomery RR, Shi Q. Alternative strategies for gene therapy of hemophilia. Hematology Am Soc Hematol Educ Program 2010; 2010: 197-202.
7. Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev 2011; 9: CD003429.
8. Berntorp E. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens. Haemophilia 2009; 15: 1219-27.
9. Duncan N, Kronenberger W, Roberson C, Shapiro A. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia 2010; 16: 247-55.
10. Lindvall K, Colstrup L, Loogna K, Wollter I, Gronhaug S. Knowledge of disease and adherence in adult patients with haemophilia. Haemophilia 2010; 16: 592-6.
11. Remor E. Predictors of treatment difficulties and satisfaction with haemophilia therapy in adult patients. Haemophilia 2011; 17: e901-5.
12. du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia 2007; 13: 493-501.
13. Gater A, Thomson TA, Strandberg-Larsen M. Haemophilia B: impact on patients and economic burden of disease. Thromb Haemost 2011; 106: 398-404.
14. Cella DF, Tulsky DS. Measuring quality of life today: methodological aspects. Oncology 1990; 4: 29-38.
15. Mackensen SV, Gringeri A. Quality of life in hemophilia. In: Lee CA, Berntorp EE, Hoots WK eds. Textbook of Hemophilia, 2nd edn. Oxford, UK: Blackwell Publishing Ltd, 2010: 401-8.
16. Bullinger M, Hasford J. Evaluating quality-of-life measures for clinical trials in Germany. Control Clin Trials 1991; 12: 91S-105S.
17. Bowling A. Health care research: measuring health status. Nurs Pract 1991; 4: 2-8.
18. FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed February 02, 2012.
19. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001; 10: 347-57.
20. Bullinger M, von Mackensen S. Quality of life assessment in haemophilia. Haemophilia 2004; 10(Suppl. 1): 9-16.
21. Remor E, Young NL, Von Mackensen S, Lopatina EG. Disease-specific quality-of-life measurement tools for haemophilia patients. Haemophilia 2004; 10(Suppl. 4): 30-4.
22. Fischer K, van der Bom JG, van den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003; 9: 75-81.
23. von Mackensen S, Bullinger M. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia 2004; 10(Suppl. 1): 17-25.
24. Szende A, Schramm W, Flood E, Larson P, Gorina E, Rentz AM et al. Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments. Haemophilia 2003; 9: 678-87.
25. Bullinger M, Globe D, Wasserman J, Young NL, von Mackensen S, on behalf of the Health Related Quality of Life Expert Working Group of the International Prophylaxis Study Group (IPSG). Challenges of patient-reported outcome assessment in haemophilia care - a state of the art review. Value Health 2009; 12: 808-20.
26. Young NL, Bradley CS, Blanchette V, Wakefield CD, Barnard D, Wu JK et al. Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004; 10: 34-43.
27. Young NL, Bradley CS, Wakefield CD, Barnard D, Blanchette VS, McCusker PJ. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer 2006; 47: 305-11.
28. Young NL, St-Louis J, Burke T, Hershon L, Blanchette V. Cross-cultural validation of the CHO-KLAT and HAEMO-QoL-A in Canadian French. Haemophilia 2012; 18: 353-7.
29. Bullinger M, Von Mackensen S, Fischer K, Khair K, Petersen C, Ravens-Sieberer U et al. Pilot testing of the Haemo-QoL quality of life questionnaire for haemophiliac children in six European countries. Haemophilia 2002; 8: 47-54.
30. Pollak E, Mühlan H, Von Mackensen S, Bullinger M, the Haemo-QoL Group. The Haemo-QoL Index: developing a short measure for health-related quality of life assessment in children and adolescents with haemophilia. Haemophilia 2006; 12: 384-92.
31. Von Mackensen S, Gringeri A. Health-related quality of life in adult patients with haemophilia - assessment with a new disease-specific questionnaire. J Thromb Haemost 2005; 3: P0813.
32. Von Mackensen S, Gringeri A. Quality of life in hemophilia, Chapter 112. In: Preedy VR, Watson RR eds. Handbook of Disease Burdens and Quality of Life. Heidelberg: Springer, 2010: 1896-920.
33. Arranz P, Remor E, Quintana M, Villar A, Díaz JL, Moreno M et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004; 10: 376-82.
34. Remor E, Arranz P, Quintana M, Villar A, Jiménez-Yuste V, Diaz JL et al. Psychometric field study of the new haemophilia quality of life questionnaire for adults: the 'Hemofilia-QoL'. Haemophilia 2005; 11: 603-11.
35. Remor E. Psychometric field study of the HemoLatin-QoL, evidence for 297 adult patients living with hemophilia in Latin American countries. Haemophilia 2008; 10: 152.
36. Remor E. Development of a disease-specific measure to the assessment of quality of life in adult patients living with hemophilia in Latin America: the Hemolatin-QoL [Desarrollo de una Medida Específica para la Evaluación de la Calidad de Vida en Pacientes Adultos Viviendo con Hemofilia en América-Latina: el Hemolatin-QoL]. Interam J Psychol 2005; 39: 211-20.
37. Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido RP et al. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008; 14: 1023-34.
38. van Genderen FR, Westers P, Heijnen L, de Kleijn P, van den Berg HM, Helders PJ et al. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006; 12: 36-46.
39. Groen WG, van der Net J, Helders PJ, Fischer K. Development and preliminary testing of a paediatric version of the haemophilia activities list (pedhal). Haemophilia 2010; 16: 281-9.
40. von Mackensen S, Czepa D, Herbsleb M, Hilberg T. Development and validation of a new questionnaire for the assessment of subjective physical performance in adult patients with haemophilia-the HEP-Test-Q. Haemophilia 2010; 16: 170-8.
41. Von Mackensen S, Gringeri A, Skovlund S. Assessment of treatment satisfaction in patients with haemophilia - development and validation of the first disease-specific questionnaire (Hemo-SatA). J Thromb Haemost 2005; 3: 0.
42. Gringeri A, Mantovani L, Mackensen SV. Quality of life assessment in clinical practice in haemophilia treatment. Haemophilia 2006; 12(Suppl. 3): 22-9.
43. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000; 25: 3186-91.
44. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.
45. Acquadro C, Conway K, Giroudet C, Mear I. Linguistic Validation Manual for Health Outcome Assessments. Lyon, France: MAPI Institute, 2012.
46. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: the example of health-related quality of life-a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002; 36: 209-38.
47. Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009; 36: 2346-55.
48. Acquadro C, Jambon B, Ellis D, Marquis P. Language and translation issues. In: Spilker B ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven, 1996: 575-85.
49. Mear I. Difficulties of international clinical trials: cultural adaptation of quality of life questionnaires. In: Chassany O, Caulin C eds. Health-Related Quality of Life and Patient-Reported Outcomes: Scientific and Useful Criteria. Paris: Springer, 2002: 55-62.